BMY Latest Headlines

Bristol-Myers Squibb: Hold Maintained as Milvexian Validation Improves, but Valuation Limits Upside

at www.tipranks.com (Tue, 10-Nov 1:06 PM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunome (IMNM) and Bristol-Myers Squibb (BMY)

at www.tipranks.com (Tue, 10-Nov 2:40 AM)

Bristol says long-term Camzyos data buoys treatment in children

at seekingalpha.com (Fri, 6-Nov 5:22 PM)

Democratic lawmakers seen probing Trump drug pricing deals come January

at seekingalpha.com (Fri, 6-Nov 12:13 PM)

Bristol Myers Squibb Sets 8:00 a.m. ET Webcast for Q3 2026 Results as Investors Await Details

Market Chameleon (Thu, 29-Oct 8:09 AM)

Bristol Myers to bring 12 oral presentations and nearly 60 oncology disclosures to ESMO 2026

Market Chameleon (Mon, 19-Oct 8:50 AM)

Bristol Myers Squibb reports Phase 3 ACTION-1 interim win for RYZ101, highlighting a potential post-Lu177 path in GEP-NETs

Market Chameleon (Mon, 12-Oct 7:30 AM)

Bristol Myers Squibb sets Oct. 29 earnings date with an 8:00 a.m. ET conference call

Market Chameleon (Fri, 18-Sep 7:06 AM)